8. Nuclear Medicine for NETs, Rathan Subramaniam, MD, PhD, UT Southwestern, 2018 Houston Conference

In this 30-minute presentation, Dr. Rathan Subramaniam, UT Southwestern, explains which Nuclear Medicine test is best for each neuroendocrine tumor grade and explains Peptide Receptor Nucleotide Therapy (PRRT). "SHOW MORE" to scan topics of interest. Click on time to view topic...

TIME TOPIC
0:50 History of somatostatin receptor imaging & therapy
1:51 Octreotide vs. Ga DOTATATE PET/CT, Grade1-2
3:04 FDG PET/CT for poorly differentiated NET, Grade 3B
4:22 Different grades and differentiation of NETs explained
6:01 What is a theranostic approach?
6:48 Grade 1 Case Study (FDG vs. DOTATATE PET)
7:52 Grade 3 Case Study (FDG vs. DOTATATE PET)
10:16 Paraganglioma Case Study
11:13 PRRT overview
16:04 PRRT Case Study: Response to Lu 177
18:09 What is it like to have Lu 177 PRRT
24:24 Experimental combination PRRT therapies
28:16 Summary
29:50 Q&A
41:00 Close